Abstract: Global Radiopharmaceuticals Market to Reach US$9. 9 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Radiopharmaceuticals estimated at US$5.
New York, July 27, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Radiopharmaceuticals Industry” – https://www.reportlinker.com/p01591554/?utm_source=GNW
3 Billion in the year 2020, is projected to reach a revised size of US$9.9 Billion by 2027, growing at a CAGR of 9.4% over the analysis period 2020-2027.SPECT Radioisotopes, one of the segments analyzed in the report, is projected to grow at a 9.3% CAGR to reach US$4.4 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the PET Radioisotopes segment is readjusted to a revised 9.5% CAGR for the next 7-year period. This segment currently accounts for a 24% share of the global Radiopharmaceuticals market.
The U.S. Accounts for Over 47.7% of Global Market Size in 2020, While China is Forecast to Grow at a 12.7% CAGR for the Period of 2020-2027
The Radiopharmaceuticals market in the U.S. is estimated at US$2.5 Billion in the year 2020. The country currently accounts for a 47.74% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$645.7 Million in the year 2027 trailing a CAGR of 12.7% through 2027. Among the other noteworthy geographic markets are…
